Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Pregabalin

Brands: Lyrica Cr · Pregabalin

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)187832
US makers4 labelers
Packages15
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.05$2.10$3.14$4.19Dec 2025Apr 2026Jul 2026
$2.966
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
4
Active US suppliers
60%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3066129181.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.1K
Rx · 2026 Q1
41K
Units dispensed
+19%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ScieGen Pharmaceuticals, Inc.unknown6SUPPLYING
Novadoz Pharmaceuticals LLCunknown3SUPPLYING
Advagen Pharma Ltdunknown3SUPPLYING
Viatris Specialty LLCunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.